$AMGN AMG 510 response rate improved to 50% from 30% in lung cancer patients. KRAS blockers are cool. #ASCO19
After years of effort with almost ALL giving up hope, the first KRAS inhibitors reveal themselves as potential cancer breakthroughs! #biopharma #persistence shines again!
Amgen’s drug — targeting an ‘undruggable’ kras mutant cancer protein — shrank tumors in half of... via
Amgen’s drug — targeting an ‘undruggable’ cancer protein — shrank tumors in half of... via
The next blockbuster? Amgen’s drug — targeting an ‘undruggable’ cancer protein via
$AMGN drug — targeting an ‘undruggable’ cancer protein — shrank tumors in half of lung cancer patients #ASCO19
Amgen drug shrank tumors in patients with 'undruggable' cancer protein